Arrhythmias & electrophysiologyCohort study

Diagnostic Impact and Prognostic Value of Cardiac Magnetic Resonance in Patients With Ventricular Arrhythmias

JACC Cardiovasc ImagingPublished

  • Prospective cohort study
  • consecutive patients

Authors' conclusion

In patients presenting with ventricular arrhythmias, multiparametric CMR assessment provides diagnostic clarification and effective risk stratification beyond current standard of care.

Study context

Population
Consecutive patients undergoing cardiac magnetic resonance (CMR) for assessment of ventricular arrhythmias
Participants
642 patients
Exposure
Abnormal vs normal CMR in patients with nonsustained ventricular tachycardia (NSVT) or sustained ventricular tachycardia (VT)/aborted sudden cardiac death (SCD)
  • NSVTn = 345
  • VT/SCDn = 297
Outcome
MACE:
  • Death
  • Recurrent VT/VF requiring therapy
  • Hospitalization for congestive HF
Follow-up
Median 4.4 years

Main finding

As reported in the abstract

MACE
Abnormal CMR vs Normal CMRHazard ratio (95% CI)P value
NSVT; multivariate model including LVEF
5.23(2.28–12.0)
P < 0.001
VT/SCD; multivariate model including LVEF
1.88(1.07–3.30)
P = 0.03

Observational data: associations, not effects.

Further findings

Structurally abnormal heart by CMR

Diagnostic change after CMR

  • Structurally abnormal heart by CMR: P < 0.001
  • Diagnostic change after CMR: P < 0.001

Incremental value of CMR in major adverse cardiac events (MACE) model (NSVT)

Significant improvement in integrated discrimination improvement and improvement in C-statistic in NSVT cohort

Original publication

Diagnostic Impact and Prognostic Value of Cardiac Magnetic Resonance in Patients With Ventricular Arrhythmias. JACC Cardiovasc Imaging. Published 14 June 2023. doi:10.1016/j.jcmg.2023.04.008

Summarised from the published abstract; every number is checked against it